Shahrokh Shabahang, CHIEF INNOVATION OFFICER at Aditx Therapeutics, Inc. (ADTX), bought 602 shares at $2.40 ($1K) on 2021-05-25, disclosed to the SEC on 2021-05-28.
Open-market purchase of $1k ADTX by CHIEF INNOVATION OFFICER. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.38 | 138 | $328 | 21.9% |
| 2 | $2.40 | 279 | $670 | 44.7% |
| 3 | $2.70 | 185 | $500 | 33.4% |
| Total | $2.49 avg | 602 | $1K | 100% |